Practice
Featured experience
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Stellex Capital Management acquisition of Fox Brothers Holdings Group
We advised Stellex Capital Management on the acquisition
SS&C Technologies $670 million acquisition of Battea-Class Action Services
We are advising SS&C on the transaction
McKesson $2.49 billion acquisition of controlling interest in Core Ventures
We are advising McKesson on the transaction
Siemens acquisition of Trayer Engineering
We advised Siemens on the transaction
Cleveland-Cliffs $600 million notes offering
We advised Cleveland-Cliffs on the offering
Gallatin Point Capital $150 million minority investment in Discount Bank
We are advising Gallatin Point on the transaction
Cheney Brothers $2.1 billion acquisition by Performance Food Group
We are advising Cheney Brothers on the transaction
Allegro MicroSystems repurchase of 39 million shares held by Sanken Electric
We advised Allegro on the share repurchase, equity offering and incremental and refinancing credit facilities
Bansk Group $1.5 billion going-private acquisition of PetIQ
We are advising Bansk Group on the transaction
Emera $1.252 billion sale of its New Mexico gas utility business
We are advising Emera on the transaction